Symrise, a global supplier of fragrances, flavorings, cosmetic active ingredients, and functional ingredients, has made a strategic equity investment in US biotech company Cellibre. This partnership will grant Symrise preferred access to Cellibre’s precision fermentation-based technology for the development of advanced manufacturing technologies for important global ingredients. By leveraging this technology, Symrise aims to accelerate the commercialization of natural flavor ingredients and cosmetic bioactives, potentially enhancing supply chain resilience by mitigating seasonal and cultivation variability.

Cellibre specializes in sustainable biomanufacturing, with expertise in engineering microorganisms for the production of natural products and chemicals. The collaboration between Symrise and Cellibre aligns with Symrise’s goal of integrating biotechnology into its operations to achieve long-term resilience, portfolio diversification, and competitive advantage. By combining scientific expertise, application know-how, and market reach, the partnership aims to unlock new growth opportunities and meet sustainability commitments, ultimately creating more resilient supply chains and delivering high-quality products with minimal impact on natural ecosystems.